These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1306457)

  • 21. Persistence of HBV-DNA in children with chronic hepatitis B who seroconverted to anti-HBs antibodies after interferon-alpha therapy: correlation with specific IgG subclass responses to HBsAg.
    Gregorek H; Dzierzanowska-Fangrat K; Woynarowski M; Jóźwiak P; Witkowska-Vogtt E; Socha J; Syczewska M; Madaliński K
    J Hepatol; 2005 Apr; 42(4):486-90. PubMed ID: 15763334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis B virus infection after renal transplantation in the presence of antibody to hepatitis B surface antigen immunity.
    Kim KH; Ahn SH; Chung HY; Paik YH; Lee KS; Kim YS; Chon CY; Moon YM; Han KH
    J Gastroenterol Hepatol; 2004 Aug; 19(8):847-53. PubMed ID: 15242485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutations in hepatitis B virus DNA from patients with coexisting HBsAg and anti-HBs.
    Chen Y; Qian F; Yuan Q; Li X; Wu W; Guo X; Li L
    J Clin Virol; 2011 Nov; 52(3):198-203. PubMed ID: 21840251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.
    Sheng WH; Kao JH; Chen PJ; Huang LM; Chang SY; Sun HY; Hung CC; Chen MY; Chang SC
    Clin Infect Dis; 2007 Nov; 45(9):1221-9. PubMed ID: 17918088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
    Behzad-Behbahani A; Mojiri A; Tabei SZ; Farhadi-Andarabi A; Pouransari R; Yaghobi R; Rahsaz M; Banihashemi M; Malek-Hosseini SA; Javid A; Bahador A; Reisjalali A; Behzadi S; Salehipour M; Salahl A; Davari R; Janghorban P; Torb A; Salah AR
    Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. De novo and apparent de novo hepatitis B virus infection after liver transplantation.
    Roche B; Samuel D; Gigou M; Feray C; Virot V; Schmets L; David MF; Arulnaden JL; Bismuth A; Reynes M; Bismuth H
    J Hepatol; 1997 Mar; 26(3):517-26. PubMed ID: 9075658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons.
    Nebbia G; Garcia-Diaz A; Ayliffe U; Smith C; Dervisevic S; Johnson M; Gilson R; Tedder R; Geretti AM
    J Med Virol; 2007 Oct; 79(10):1464-71. PubMed ID: 17705185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepatitis B vaccination.
    Zhu CL; Liu P; Chen T; Ni Z; Lu LL; Huang F; Lu J; Sun Z; Qu C
    Vaccine; 2011 Oct; 29(44):7835-41. PubMed ID: 21816197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
    Kuhns MC; Kleinman SH; McNamara AL; Rawal B; Glynn S; Busch MP;
    Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hepatitis B virus DNA detection by means of polymerase chain reaction in patients with chronic hepatitis and hepatocellular carcinoma].
    Song Y; Pan W; Fan Z; Du P; Qi Z
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):220-2. PubMed ID: 15617333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Investigation of occult hepatitis B in HIV infected patients].
    Altınbaş A; Ergünay K; Calık Başaran N; Alp A; Turgut D; Hasçelik G; Uzun Ö; Unal S
    Mikrobiyol Bul; 2011 Apr; 45(2):353-8. PubMed ID: 21644079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PreS antigen expression and anti-preS response in hepatitis B virus infections: relationship to serum HBV-DNA, intrahepatic HBcAg, liver damage and specific T-cell response.
    Petit MA; Capel F; Zoulim F; Dubanchet S; Chemin I; Penna A; Ferrari C; Trépo C
    Arch Virol Suppl; 1992; 4():105-12. PubMed ID: 1280500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low levels of awareness, vaccine coverage, and the need for boosters among health care workers in tertiary care hospitals in India.
    Sukriti ; Pati NT; Sethi A; Agrawal K; Agrawal K; Kumar GT; Kumar M; Kaanan AT; Sarin SK
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1710-5. PubMed ID: 18761556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Studies on hepatitis B virus infection in blood donors with positive anti-HBc and negative HBsAg].
    Ren F; Li H; Zhao H
    Zhonghua Yu Fang Yi Xue Za Zhi; 1998 Jan; 32(1):7-9. PubMed ID: 10322742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study of hepatitis B (HB) vaccine non-responsiveness among health care workers from an endemic area (Taiwan).
    Yen YH; Chen CH; Wang JH; Lee CM; Changchien CS; Lu SN
    Liver Int; 2005 Dec; 25(6):1162-8. PubMed ID: 16343067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Donor screening for hepatitis B virus infection in a cell and tissue bank.
    Solves P; Mirabet V; Alvarez M; Vila E; Quiles F; Villalba JV; Montoro JA; Soler MA; Roig RJ
    Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Change of hepatitis B virus DNA status in anti-HBc positive liver graft.
    Kwon CH; Suh KS; Cho JY; Yi NJ; Jang JJ; Lee KU
    Korean J Hepatol; 2006 Jun; 12(2):191-200. PubMed ID: 16804344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The novel use of a routine quantitative system to analyze the activity, content and affinity of an antibody to hepatitis B core antigen.
    Han Y; Wang B; Liu H
    J Clin Virol; 2011 Dec; 52(4):295-9. PubMed ID: 21978612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Community-based research: cost of the tests used for anti-HBc total seropositivity only and hepatitis B screening.
    Ozkan S; Atak A; Bozdayi G; Turkcuoglu S; Maral I
    Trans R Soc Trop Med Hyg; 2010 Dec; 104(12):782-6. PubMed ID: 20889180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
    Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
    Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.